AstraZeneca has reinforced its commitment to vaccines. And it has done so with the acquisition of Omniose, an American biotechnology company specialized in the development of conjugated vaccines against serious bacterial infections. The company, based in St. Louis (Misuri), will be integrated into the Division of Infectious Diseases of the British laboratory, according to Omniose [...] The entry AstraZeneca acquires Omniose to strengthen its vac…